Product Information
ZEMBRACE SYMTOUCH 3 MG/0.5 ML is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $383.9990 per ML under NDC 00245080938. Its NADAC has been published 190 times since May 5, 2021.
FDA first approved this application on Jan 28, 2016.
The High Outlier badge above means this manufacturer's average price in the Sumatriptan Succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245080938
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA208223FDA Approved
1/28/2016
On Market Since
2/22/2016
Pharmacological Classes
Price Statistics
The NADAC for ZEMBRACE SYMTOUCH 3 MG/0.5 ML has been published 190 times since May 5, 2021, and over the history we have for it it has risen 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $383.9990 per ML |
|---|---|
| All-time high | $384.6373 (Apr 15, 2026) |
| All-time low | $330.2767 (May 5, 2021) |
| 52-week high | $384.6373 |
| 52-week low | $381.4340 |
| Median price | $382.6344 |
| Average price | $364.6352 |
| Largest weekly change | +7.8% (Feb 21, 2024) |
| Weeks tracked | 190 |
| Tracking since | May 5, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sumatriptan Succinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZEMBRACE SYMTOUCH 3 MG/0.5 ML?
The current National Average Drug Acquisition Cost (NADAC) for ZEMBRACE SYMTOUCH 3 MG/0.5 ML, manufactured by Upsher-Smith Laboratories LLC, is $383.9990 per ML (NDC 00245080938), effective Aug 19, 2026.
How has the price of ZEMBRACE SYMTOUCH 3 MG/0.5 ML changed over time?
Over the history we have for it, the NADAC for ZEMBRACE SYMTOUCH 3 MG/0.5 ML has risen 16.3%. It has been tracked across 190 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for ZEMBRACE SYMTOUCH 3 MG/0.5 ML?
Since May 5, 2021, the NADAC for ZEMBRACE SYMTOUCH 3 MG/0.5 ML has ranged from a low of $330.2767 (May 5, 2021) to a high of $384.6373 (Apr 15, 2026), with a median of $382.6344 per ML.
Are there cheaper alternatives to ZEMBRACE SYMTOUCH 3 MG/0.5 ML?
No other NADAC-published product currently shares the active ingredient and strength of ZEMBRACE SYMTOUCH 3 MG/0.5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZEMBRACE SYMTOUCH 3 MG/0.5 ML?
ZEMBRACE SYMTOUCH 3 MG/0.5 ML (NDC 00245080938) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.